Catalyst Wire Dossier Catalyst Wire Dossier

Q-Cells (human glial restricted progenitor cells)

human glial restricted progenitor cells · Q Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Q-Cells (human glial restricted progenitor cells), covering 2023-08-21 to 2023-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

See pricing